IBDEI12A ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,38550,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,38550,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,38551,0)
 ;;=L30.2^^148^1936^132
 ;;^UTILITY(U,$J,358.3,38551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38551,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,38551,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,38551,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,38552,0)
 ;;=L30.4^^148^1936^144
 ;;^UTILITY(U,$J,358.3,38552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38552,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,38552,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,38552,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,38553,0)
 ;;=L30.8^^148^1936^135
 ;;^UTILITY(U,$J,358.3,38553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38553,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,38553,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,38553,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,38554,0)
 ;;=L30.9^^148^1936^136
 ;;^UTILITY(U,$J,358.3,38554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38554,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,38554,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,38554,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,38555,0)
 ;;=L40.0^^148^1936^253
 ;;^UTILITY(U,$J,358.3,38555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38555,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,38555,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,38555,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,38556,0)
 ;;=L40.1^^148^1936^256
 ;;^UTILITY(U,$J,358.3,38556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38556,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,38556,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,38556,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,38557,0)
 ;;=L40.2^^148^1936^11
 ;;^UTILITY(U,$J,358.3,38557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38557,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,38557,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,38557,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,38558,0)
 ;;=L40.3^^148^1936^255
 ;;^UTILITY(U,$J,358.3,38558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38558,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,38558,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,38558,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,38559,0)
 ;;=L40.4^^148^1936^157
 ;;^UTILITY(U,$J,358.3,38559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38559,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,38559,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,38559,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,38560,0)
 ;;=L40.8^^148^1936^252
 ;;^UTILITY(U,$J,358.3,38560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38560,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,38560,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,38560,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,38561,0)
 ;;=L40.9^^148^1936^254
 ;;^UTILITY(U,$J,358.3,38561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38561,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,38561,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,38561,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,38562,0)
 ;;=L50.9^^148^1936^286
 ;;^UTILITY(U,$J,358.3,38562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38562,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,38562,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,38562,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,38563,0)
 ;;=L53.8^^148^1936^147
 ;;^UTILITY(U,$J,358.3,38563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38563,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,38563,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,38563,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,38564,0)
 ;;=L53.9^^148^1936^146
 ;;^UTILITY(U,$J,358.3,38564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38564,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,38564,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,38564,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,38565,0)
 ;;=L54.^^148^1936^145
 ;;^UTILITY(U,$J,358.3,38565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38565,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,38565,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,38565,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,38566,0)
 ;;=L56.0^^148^1936^139
 ;;^UTILITY(U,$J,358.3,38566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38566,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,38566,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,38566,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,38567,0)
 ;;=L56.1^^148^1936^138
 ;;^UTILITY(U,$J,358.3,38567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38567,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,38567,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,38567,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,38568,0)
 ;;=L56.2^^148^1936^236
 ;;^UTILITY(U,$J,358.3,38568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38568,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,38568,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,38568,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,38569,0)
 ;;=L56.3^^148^1936^268
 ;;^UTILITY(U,$J,358.3,38569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38569,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,38569,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,38569,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,38570,0)
 ;;=L57.0^^148^1936^12
 ;;^UTILITY(U,$J,358.3,38570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38570,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,38570,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,38570,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,38571,0)
 ;;=L60.0^^148^1936^161
 ;;^UTILITY(U,$J,358.3,38571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38571,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,38571,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,38571,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,38572,0)
 ;;=L60.1^^148^1936^234
 ;;^UTILITY(U,$J,358.3,38572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38572,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,38572,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,38572,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,38573,0)
 ;;=L60.2^^148^1936^233
 ;;^UTILITY(U,$J,358.3,38573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38573,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,38573,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,38573,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,38574,0)
 ;;=L60.3^^148^1936^170
 ;;^UTILITY(U,$J,358.3,38574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38574,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,38574,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,38574,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,38575,0)
 ;;=L60.4^^148^1936^88
 ;;^UTILITY(U,$J,358.3,38575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38575,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,38575,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,38575,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,38576,0)
 ;;=L60.5^^148^1936^290
 ;;^UTILITY(U,$J,358.3,38576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38576,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,38576,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,38576,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,38577,0)
 ;;=L60.8^^148^1936^168
 ;;^UTILITY(U,$J,358.3,38577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38577,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,38577,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,38577,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,38578,0)
 ;;=L62.^^148^1936^169
 ;;^UTILITY(U,$J,358.3,38578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38578,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,38578,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,38578,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,38579,0)
 ;;=L64.9^^148^1936^33
 ;;^UTILITY(U,$J,358.3,38579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,38579,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,38579,1,4,0)
 ;;=4^L64.9
